ber of 19 coding exons makes this method quite labori-A new method is described for detection of muta-ous. In this paper we describe a new approach to mutations in the lysosomal a-glucosidase gene (GAA) lead-tion detection in GSDII which is based on reverse ing to Glycogen Storage Disease type II (GSDII). A key transcription of mRNA followed by cDNA amplification feature of the method is isolation and reverse tran-and sequence analysis on an ABI PRISM 377 DNA scription of mRNA followed by PCR amplification of sequencing system using dye-labeled primers in the lysosomal a-glucosidase cDNA with M13-extended cycle sequencing reaction. EC. 3.2.1.3.) due to mutations in the GAA gene (1,2).
The splice site is lost and a cryptic splice donor site in EC. 3.2.1.3.) due to mutations in the GAA gene (1, 2) .
DNA and RNA isolation. Genomic DNA was extracted from culThe clinical phenotype is primarily determined by the tured fibroblasts using routine procedures (7) . RNA was extracted nature of these mutations and the allelic combination using RNAzol TM reagent according to the manufacturer's directions in which they occur. Skeletal muscle weakness is the (Tel-Test, U.S.A.). Northern blot analysis was as described (6) . common clinical feature and is rapidly progressive Mutation analysis. To perform RT-PCR and cycle sequencing, when the enzyme deficiency is complete and slowly pro-cDNA was made from 1 mg RNA using the Superscript TM Preamplifigressive when residual activity remains. Patients with cation System and 100 ng random hexamer primers in a total volume of 20 ml (Gibco BRL). PCR was performed using an appropriate pair the most severe infantile form of the disease succumb of forward and reverse primers complementary to the GAA cDNA in the first year of life by cardiorespiratory failure (3); sequence ( Table 1 ). The PCR reaction was performed in a final volpatients with late onset GSDII suffer mainly from skel-ume of 50 ml containing 10 pmol of each of the primers, a 2 ml aliquot etal muscle weakness and respiratory problems (4, 5 (6) . Northern blot analysis failed to demonstrate lysoGenomic DNA was PCR amplified using intronic and exonic primsomal a-glucosidase mRNA in cells of the patient sugers specific for the GAA gene as described (8) . Cycle sequencing was gesting the presence of a mutation inhibiting transcripas described above, except that the ABI PRISM TM Dye Terminator tion or destabilizing the lysosomal a-glucosidase
Cycle Sequencing Ready Reaction Kit was used (Perkin Elmer).
mRNA ( Figure 1 ). When RT-PCR was performed as described above RESULTS AND DISCUSSION DNA fragments (A-F) of proper size were obtained with
To identify the mutations responsible for lysosomal a-glucosidase deficiency in patients suffering from GSDII we have in the past PCR-amplified and sequenced all 19 exons of the GAA gene using exon flanking primers. This method has been quite effective but laborious.
In this report we describe a new approach to identify mutations starting from the patient's mRNA and sequencing first the cDNA by RT-PCR before embarking on genomic DNA analysis. One confluent 25 cm 2 tissue culture flask with fibroblasts of the patient is sufficient for RNA extraction and reverse transcription into cDNA using random hexamer primers. The lysosomal a-glucosidase cDNA is amplified with 6 sets (A-F) of sequence specific primers which are fused to either the-21 M13 forward or the M13 reverse primer sequence Primer Cycle Sequencing Kits ( Table 1) . The primer mRNA, the open arrow head to 28S ribosomal RNA which can be sets were chosen such to obtain a high fidelity method used to compare the amount of RNA in each lane. P: patient; C:
for PCR amplification and cycle sequencing. The its apparently transcription or causes instability of the mRNA since no signal is detected on Northern blot.
To further test the RT-PCR automated sequencing approach, the complete open reading frame contained in fragments A-F was sequenced. The sequences of all PCR fragments could be analyzed readily in both directions. No other deleterious mutations were found besides IVS16(/2T r C) but several polymorphisms were detected; all homozygous (Table 2) .
Of the more than 40 mutations that have been identified in the GAA gene, only few affect splicing. The most frequent GAA mutation, IVS1(-13T r G), is conditional for the skipping of exon 2 by aberrant splicing (9, 10) . Approximately 10-40% of the lysosomal a-glucosidase mRNA is correctly spliced (10-12). This mutation is found world wide and is associated with late onset GSDII when combined with a null allele (9, (12) (13) (14) . The two other splice site mutations presently known are IVS6- patient results in the activation of a cryptic splice site.
The advantage of our new approach towards mutation detection is evident. Only 6 (cDNA) fragments need 5 of the 6 primer sets illustrating the superior sensitiv-to be amplified and sequenced instead of the 18 genomic ity of the RT-PCR method over Northern blotting (Fig-fragments (8,16) . The new method is very sensitive so ure 2).
that the same small number of cells can be used for Fragment E of the patient was never amplified, de-RNA extraction as for the isolation of genomic DNA. spite the fact that the experiment was repeated several times. This made us aware that a mutation could be located at either the M13f-E or M13r-E primer site. Using M13f-E and M13r-E in combination with several other primers the amplification problem appeared to be associated with primer M13r-E spanning the boundary of exon 16 and 17. Thus, we amplified a cDNA and genomic fragment spanning this boundary and observed a small, 10-20 base pair, deletion in the cDNA fragment but not in the genomic DNA of the patient (Figure 3) . We then sequenced the cDNA and genomic fragments to find the precise molecular defect and discovered that the last 16 base pairs of exon 16 were deleted in the cDNA (del. 2315-2330; Figure 4A ). The deletion comprises the last eight 3-nucleotides of primer M13r-E; an obvious reason why this primer does not function. The genomic DNA sequence revealed only a single base pair substitution, a T to C transition at position /2 in the splice donor site of exon 16 (designated IVS16(/2T r C); Figure 4B ). Combining the se- gous for this mutation. This splice site mutation inhib- under Accession Nos. X55079-X55098.
In conclusion, we have demonstrated the use of a new and rapid approach to identify the molecular defects in lysosomal a-glucosidase. The complete open reading frame is amplified in 6 overlapping fragments starting from mRNA rather than genomic DNA, and is sequenced entirely both in forward and reverse directions using the automated sequencing technology. The IVS16(/2T r C) transition, leading to a 16 base pairs deletion on cDNA is the first mutation that we have found with this approach.
